Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability and Safety of BAY 2328065 in Healthy Volunteers
NCT04851483Phase 1Completed
- Sponsor
- Bayer
- Start
- Apr 2021
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of BAY2328065 in endometriosis (5 arms), sponsored by Bayer. Primary endpoints: Number of subjects with treatment-emergent adverse events, Severity of treatment-emergent adverse events and 2 more. Started Apr 2021; status: completed.
02
Drugs
BAY2328065
03
Conditions
endometriosis
Beyond the preview
Go deeper on NCT04851483.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04851483.